During the past decade, USF Health Byrd Alzheimer's Institute conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 8 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "USF Health Byrd Alzheimer's Institute" #1 sponsor was "Biogen" with 4 trials, followed by "University of Southern California" with 4 trials sponsored, "Alzheimer's Disease Cooperative Study (ADCS)" with 3 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored and "University of South Florida" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "USF Health Byrd Alzheimer's Institute" #1 collaborator was "National Institute on Aging (NIA)" with 10 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 5 trials as a collaborator, "Northern California Institute of Research and Education" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator and "Alzheimer's Association" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "USF Health Byrd Alzheimer's Institute" are "Alzheimer's Disease" (15 trials), "Alzheimer Disease" (11 trials), "Alzheimer Disease, Late Onset" (2 trials), "Alzheimer's Disease (AD)" (2 trials) and "Alzheimers Disease" (2 trials). Many other conditions were trialed in "USF Health Byrd Alzheimer's Institute" in a lesser frequency.

Most popular intervention types in "USF Health Byrd Alzheimer's Institute" are "Drug" (28 trials), "Other" (4 trials), "Device" (3 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "Aducanumab" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "MemorEM 1000" (2 trials). Other intervention names were less common.

The vast majority of trials in "USF Health Byrd Alzheimer's Institute" are 37 trials for "All" genders.

Currently, there are NaN active trials in "USF Health Byrd Alzheimer's Institute". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in USF Health Byrd Alzheimer's Institute, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in USF Health Byrd Alzheimer's Institute, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".